| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |